- Home
- EVCM vs GPCR Comparison
EVCM vs GPCR Comparison
Compare EVCM & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVCM
- GPCR
- Stock Information
- Founded
- EVCM 2006
- GPCR 2016
- Country
- EVCM United States
- GPCR United States
- Employees
- EVCM N/A
- GPCR N/A
- Industry
- EVCM EDP Services
- GPCR
- Sector
- EVCM Technology
- GPCR
- Exchange
- EVCM Nasdaq
- GPCR Nasdaq
- Market Cap
- EVCM 1.9B
- GPCR 1.6B
- IPO Year
- EVCM 2021
- GPCR 2023
- Fundamental
- Price
- EVCM $10.08
- GPCR $29.33
- Analyst Decision
- EVCM Buy
- GPCR Strong Buy
- Analyst Count
- EVCM 9
- GPCR 7
- Target Price
- EVCM $12.56
- GPCR $81.29
- AVG Volume (30 Days)
- EVCM 78.8K
- GPCR 819.8K
- Earning Date
- EVCM 03-13-2025
- GPCR 03-07-2025
- Dividend Yield
- EVCM N/A
- GPCR N/A
- EPS Growth
- EVCM N/A
- GPCR N/A
- EPS
- EVCM N/A
- GPCR N/A
- Revenue
- EVCM $693,206,000.00
- GPCR N/A
- Revenue This Year
- EVCM $4.85
- GPCR N/A
- Revenue Next Year
- EVCM $4.17
- GPCR N/A
- P/E Ratio
- EVCM N/A
- GPCR N/A
- Revenue Growth
- EVCM 3.82
- GPCR N/A
- 52 Week Low
- EVCM $6.22
- GPCR $23.50
- 52 Week High
- EVCM $12.35
- GPCR $62.74
- Technical
- Relative Strength Index (RSI)
- EVCM 38.14
- GPCR 47.54
- Support Level
- EVCM $9.81
- GPCR $27.64
- Resistance Level
- EVCM $10.68
- GPCR $31.72
- Average True Range (ATR)
- EVCM 0.30
- GPCR 1.52
- MACD
- EVCM 0.01
- GPCR 0.46
- Stochastic Oscillator
- EVCM 29.35
- GPCR 55.77
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts..
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.